ArticleJournal for immunotherapy of cancer2019

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.

Yiyin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.